316 related articles for article (PubMed ID: 8204923)
1. [Hereditary predisposition for cancer of the breast and the ovary].
Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod SA; Sobol H; Bignon YJ
Bull Cancer; 1993 Oct; 80(10):857-65. PubMed ID: 8204923
[TBL] [Abstract][Full Text] [Related]
2. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.
Stratton MR; Ford D; Neuhasen S; Seal S; Wooster R; Friedman LS; King MC; Egilsson V; Devilee P; McManus R
Nat Genet; 1994 May; 7(1):103-7. PubMed ID: 8075631
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
[TBL] [Abstract][Full Text] [Related]
4. DNA screening for breast/ovarian cancer susceptibility based on linked markers. A family study.
Lynch HT; Watson P; Conway TA; Lynch JF; Slominski-Caster SM; Narod SA; Feunteun J; Lenoir G
Arch Intern Med; 1993 Sep; 153(17):1979-87. PubMed ID: 8357282
[TBL] [Abstract][Full Text] [Related]
5. Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal bilateral breast cancer.
Cortessis V; Ingles S; Millikan R; Diep A; Gatti RA; Richardson L; Thompson WD; Paganini-Hill A; Sparkes RS; Haile RW
Cancer Res; 1993 Nov; 53(21):5083-6. PubMed ID: 8221639
[TBL] [Abstract][Full Text] [Related]
6. Linkage analysis of 19 French breast cancer families, with five chromosome 17q markers.
Mazoyer S; Lalle P; Narod SA; Bignon YJ; Courjal F; Jamot B; Dutrillaux B; Stoppa-Lyonnett D; Sobol H
Am J Hum Genet; 1993 Apr; 52(4):754-60. PubMed ID: 8096359
[TBL] [Abstract][Full Text] [Related]
7. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
[TBL] [Abstract][Full Text] [Related]
8. Familial breast-ovarian cancer locus on chromosome 17q12-q23.
Narod SA; Feunteun J; Lynch HT; Watson P; Conway T; Lynch J; Lenoir GM
Lancet; 1991 Jul; 338(8759):82-3. PubMed ID: 1676470
[TBL] [Abstract][Full Text] [Related]
9. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
[TBL] [Abstract][Full Text] [Related]
10. Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22.
Rahman N; Teare MD; Seal S; Renard H; Mangion J; Cour C; Thompson D; Shugart Y; Eccles D; Devilee P; Meijers H; Nathanson KL; Neuhausen SL; Weber B; Chang-Claude J; Easton DF; Goldgar D; Stratton MR
Oncogene; 2000 Aug; 19(36):4170-3. PubMed ID: 10962578
[TBL] [Abstract][Full Text] [Related]
11. Analysis of breast cancer pedigrees using affected sibship methods.
Barrett JH; Rigby AS
Genet Epidemiol; 1995; 12(6):847-51. PubMed ID: 8788020
[TBL] [Abstract][Full Text] [Related]
12. Familial ovarian carcinoma: pedigree studies and preliminary results from linkage analysis.
Sobol H; Mazoyer S; Smith SA; Lyonnet D; Bignon YJ; Narod SA; Ardoin A; Biron P; Bobin JY; Bremond A
Bull Cancer; 1993 Feb; 80(2):121-34. PubMed ID: 8173163
[TBL] [Abstract][Full Text] [Related]
13. An investigation to determine whether clusters of cancer types exist in nine breast-ovary families.
Bansal A; Bishop DT; Cannings C
Genet Epidemiol; 1995; 12(6):841-6. PubMed ID: 8788019
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 susceptibility markers and postmenopausal breast cancer: the Iowa Women's Health Study.
Thompson JA; Chen PL; King RA; Rich SS; Oetting WS; Armstrong C; Folsom AR; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):507-11. PubMed ID: 10815696
[TBL] [Abstract][Full Text] [Related]
15. Hereditary breast and ovarian cancer: epidemiology, genetics, screening and predictive testing.
Foulkes WD; Narod SA
Clin Invest Med; 1995 Dec; 18(6):473-83. PubMed ID: 8714791
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
17. Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families.
Seitz S; Rohde K; Bender E; Nothnagel A; Kölble K; Schlag PM; Scherneck S
Oncogene; 1997 Feb; 14(6):741-3. PubMed ID: 9038382
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
Narod SA; Ford D; Devilee P; Barkardottir RB; Lynch HT; Smith SA; Ponder BA; Weber BL; Garber JE; Birch JM
Am J Hum Genet; 1995 Jan; 56(1):254-64. PubMed ID: 7825586
[TBL] [Abstract][Full Text] [Related]
19. Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer.
Torchard D; Blanchet-Bardon C; Serova O; Langbein L; Narod S; Janin N; Goguel AF; Bernheim A; Franke WW; Lenoir GM
Nat Genet; 1994 Jan; 6(1):106-10. PubMed ID: 7511021
[TBL] [Abstract][Full Text] [Related]
20. Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations.
Gallardo M; Silva A; Rubio L; Alvarez C; Torrealba C; Salinas M; Tapia T; Faundez P; Palma L; Riccio ME; Paredes H; Rodriguez M; Cruz A; Rousseau C; King MC; Camus M; Alvarez M; Carvallo P
Breast Cancer Res Treat; 2006 Jan; 95(1):81-7. PubMed ID: 16261400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
